Translate this page into:
Fabrication, characterization, thermal stability and nanoassemblies of novel pullulan-aspirin conjugates
⁎Corresponding author. Tel.: +92 3468614959. majaz172@yahoo.com (Muhammad A. Hussain)
-
Received: ,
Accepted: ,
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Present study deals with homogeneous and one-pot synthesis of novel macromolecular prodrugs (MPDs) of aspirin onto naturally occurring hydrophilic biopolymer pullulan. Pullulan-aspirin conjugates were synthesized by using green carboxylic acid activating reagent 1,1′-carbonyldiimidazole (CDI). The aspirin was first reacted with CDI to prepare aspirin-imidazolide at RT for 24 h which in situ reacted with pre-dissolved pullulan and the reaction preceded further for 24 h at 80 °C under nitrogen. Degree of substitution (DS 0.32–0.40) of aspirin onto pullulan was calculated from 1H NMR spectroscopy. Spectroscopic techniques confirmed the high covalent drug loading and purity. Thermal analysis has revealed that new MPDs of aspirin are thermally more stable than pure aspirin. The activation energy, order and frequency factor of the degradation reactions were calculated using Broido, Friedman and Chang models. The amphiphilic pullulan-aspirin conjugates self-assembled in nanoparticles without further structural modifications at solvent interface in the range of 500–680 nm as examined by transmission electron microscopy. These novel pullulan-aspirin conjugates with masked COOH functional group could be potentially safe prodrugs for the stomach.
Keywords
Biopolymers
Pullulan-aspirin conjugates
Nanoparticles
Thermal properties
Aspirin
Esterification
1 Introduction
Hydrophilic biopolymers, especially, glycopolymers are getting greater attention nowadays for the formation of macromolecular prodrugs (MPDs). Polysaccharides based MPD design is widely accepted and proved for better pharmaceutical and pharmacological properties (Callant and Schacht, 1990; Hussain et al., 2011a,b; Vinsova and Vaverikova, 2008; Jain et al., 2007). Almost all of the polysaccharides used for the purpose are nontoxic, biocompatible and cheaper drug careers. A number of non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics (Kumar et al., 2013; Sharma and Sharma, 2008) and anticancer agents (Duncan et al., 2001) have been reported as polyglucan based prodrugs. By this approach, some useful properties can be easily achieved, e.g., better pharmacokinetic profile, increased tolerance and reduction in dose frequency. Additionally, MPD design reduces work load on the kidney, provides wider drug distribution and sustained/delayed drug release (Sharma and Sharma, 2008).
Polysaccharide based prodrug design can be achieved by simple conversion of hydroxyl groups to esters and amides after reactions with drugs (Pappas et al., 2006; Sandrine et al., 2005; Takakura, 1996). By these reactions, carboxylic acids or carboxylic acid containing drugs, e.g., NSAIDs can be attached with the polymer backbones (Kim and Na, 2010; Park et al., 2012; Babazadeh, 2006; Hussain et al., 2009, 2011a,b). Previously, acid chlorides and anhydrides (Hussain et al., 2010b,a) of the drug molecules containing carboxylic acid and sulfonic acid catalyzed products were allowed to react with hydroxyls of polysaccharides. However, nowadays homogenous reaction methodologies (Glasser et al., 2000; Shimoda et al., 2012; Liebert et al., 2011) along with the use of in situ carboxylic acid activating reagents are the prodrug design strategies. Weak and sensitive carboxylic acid containing drugs toward esterification reactions are first activated with RCOOH acid activating reagents (Hussain and Heinze, 2008; Liebert et al., 2006) that include p-toluenesulfonyl chloride (Hussain et al., 2013), 1,1′-carbonyldiimidazole (CDI) (Hussain et al., 2004b), and iminium chlorides (Hussain et al., 2004a), etc. CDI is one of the powerful and safest reagents as imidazole generated in situ acts as a base to neutralize acidic impurities. The macromolecular drug conjugates are tuned in such a way to achieve amphiphilic nature of the conjugates as a whole. Therefore, by tuning the degree of substitution of pendant drug molecules, the resultant MPDs self-assembled in nanoparticles. We have recently reported a novel nanoparticulate drug design of aspirin onto a hydrophilic biopolymer i.e., hydroxypropylmethylcellulose (HPMC) (Hussain et al., 2011a,b). Moreover, nano-particulate HPMC-aspirin conjugates have shown delayed release and improved pharmacokinetics.
Our aim was to design pullulan based prodrugs of aspirin and to study their properties. In addition to the synthesis of nonionic, acid resistant, neutral, and biocompatible novel bioconjugates of aspirin, it offers safety to the stomach from hyperacidity and colon targeted drug delivery. One can exploit controlled/sustained release of these newly designed MPDs as a future aspect of the present work. We were also focused to study self-assembly of pullulan-aspirin conjugates in solution without further structure modification. Self-assembled nanoparticles, thermal degradation and kinetics of the novel polymeric aspirin conjugates are being reported for the first time.
2 Experimental
2.1 Materials
Aspirin (US Pharmacopoeia standards) used was gifted by Askari Pharmaceuticals, Pakistan. 1,1′-Carbonyldiimazole (CDI) was obtained from Aldrich while pullulan was purchased from IL, USA. Analytical grade N,N-dimethylacetamide (DMA), anhydrous lithium chloride and other chemicals were used as received from Fluka.
2.2 Instrumentation
The FTIR (KBr pellet technique) spectra (ν, cm−1) were acquired on IR Prestige-21 (Shimadzu, Japan).
The 1H NMR spectra (δ, ppm; DMSO-d6, NS 16) of pullulan-aspirin conjugates were recorded on Bruker 400 MHz machine while for 13C NMR 5000 Scans were accumulated.
Thermal degradation studies were performed on a SDT Q 600 (TA Instruments, USA) thermal analyzer. The thermal spectra were recorded at the onset of significant weight loss under nitrogen at a constant heating rate of 10 °C/min from RT up to 800 °C.
The products were studied by transmission electron microscopy (TEM) for self-assemblies. TEM used was Philips 420 instrument with an acceleration voltage of 120 kV.
2.3 Dissolution of pullulan
Pullulan was dried under vacuum at 110 °C before dissolution for 1 h. Dry pullulan (2 g) was dissolved in DMA (30 mL) by stirring at 90 °C. Polymer was dissolved within 25 min with optical clarity.
2.4 Synthesis of pullulan-aspirin conjugates 1, a typical example
Aspirin (2.22 g, 12.33 mmol) was dissolved in DMF (40 mL) solvent and CDI (1.99 g, 12.33 mmol) was added in parts under nitrogen atmosphere. Reaction mixture was stirred for 24 h at RT for the synthesis of reactive imidazolide of aspirin. This reaction mixture was added slowly to the solution of pullulan (2 g, 12.33 mmol) in DMA. Reaction mixture was continuously stirred at 80 °C for 24 h under nitrogen. Isolation of the product was carried out by precipitation of reaction mixture into 200 mL ethanol. The precipitates of sample 1 were washed thoroughly with ethanol in order to remove any of the side products and un-reacted drug contents. Precipitates of pullulan-aspirin conjugate 1 were dried under vacuum at 50 °C. Similar reaction procedures were adopted for the rest of pullulan-aspirin conjugates. Yield: 1.95 g (76%); DS = 0.32 by 1H NMR spectroscopy; FTIR (KBr): ν = 3431 (OH), 2926 (aromatic C–H), 1740 (C⚌O ester), 1462 (CH2) cm−1; 1H NMR (400 MHz, DMSO-d6, δ): 1.98 (H-7), 3.35–5.70 (AGU-H-1-6), 6.94 (H-9,11), 7.50 (H-10), 7.86 (H-8) ppm; 13C NMR (DMSO-d6, δ): 170.49 (C-8), 168.99 (C-7), 117.75 (C-1), 119.90 (C-3), 130.61 (C-5), 136.16 (C-6), 136.26 (C-4), 160.61 (C-2), 101.84 & 95.99 (C-10), 74.45-67.5 (C11–14), 60.56 (C-15), 21.08 (C-9) ppm.
2.5 Transmission electron microscopy
Nanoparticles of pullulan-aspirin conjugates 3 were prepared using dialysis process. Sample 3 (20 mg) was taken in a typical batch, dissolved in purified DMSO (5 mL). Dialysis process was continued for 4 days against water along with constant stirring. The nanoparticle suspension was concentrated. The TEM samples were prepared using drop casting on carbon coated copper grids. The TEM grids were dried under air before studying by TEM.
2.6 Thermal degradation kinetic analysis
The kinetics of thermal decomposition of pullulan-aspirin conjugates were examined by Friedman, Broido and Chang methods. Friedman kinetic model (Friedman, 1964) uses the following equation; where, dα/dt is the rate of weight loss directly taken from the DTG curve; Z is the frequency factor of decomposition reaction; n is the reaction order; 1−α is the weight of sample left at a certain temperature that is also taken from the TG curve; Ea is the activation energy; R is the gas constant and T is the absolute temperature recorded.The order of the reaction was calculated from the Chang model as given below (Chang, 1994). A straight line was obtained when ln [(dα/dt)/(1−α)n] was plotted versus 1/T in case if the assumed n value is found correct. The slope and intercept of the straight line were used to calculate the Ea and Z values.
The Broido method (Broido, 1969) was also used to calculate kinetic parameters, i.e., Ea and Z as per following equation. where, y = (wt−w∞)/(w0−w∞), wt = weight at a given time t, w0 = initial weight and w∞ is final weight.
3 Results and discussion
3.1 Synthesis and characterization
The MPDs of aspirin with a hydrophilic polysaccharide, i.e., pullulan, were synthesized using one pot and homogeneous reaction conditions (Samples 1–4). Pre-dissolved pullulan was reacted with imidazolide of aspirin drug prepared after activation of its carboxylic acid functional group with 1,1′-carbonyldiimidazole (CDI). Reaction methodology is generalized in Scheme 1.
Aspirin was first activated with a fascinating RCOOH activating reagent CDI. CDI reacts with RCOOH of aspirin to make its imidazolide. Imidazolide was then reacted with the –OH functional groups of the anhydroglucose units (AGU) of pullulan to generate ester linkage. In this way, ester conjugates as MPDs of aspirin were successfully synthesized. A base imidazole was generated in situ that neutralizes the unreacted drug therefore no extra base is needed during the reaction. Pullulan-aspirin conjugates 1–4 were fabricated by using different mole ratios of the reactants (AGU:CDI:aspirin). The results of esterification reactions are given in Table 1 for all newly fabricated MPDs of aspirin onto pullulan.
Aspirin has been previously attached with another cellulose derivative i.e., hydroxypropylmethylcellulose (HPMC). Although, it was pioneering work for the attachment of aspirin onto any ether derivative of cellulose the reaction resulted in low DS of aspirin onto HPMC (Hussain et al., 2011a,b). The DS of aspirin in HPMC-aspirin conjugates was obtained in the range of 0.04–0.14. However, considerably high drug loading was achieved in the present study. Ds. was found in the range of 0.32–0.40 for pullulan-aspirin conjugates with same mole ratios of drug to polymer. This increased drug loading can potentially reduce the size of dose.
Aspirin prodrugs synthesized by the CDI method were found soluble in different organic solvents, i.e., DMSO, DMF, acetone and DMA. The products were thoroughly characterized by using different spectroscopic techniques. Thermogravimetric (TG) analyses were used to determine the stability of the fabricated MPDs. Transmission election microscopy (TEM) was used to study nanoassemblies in solution. The detailed structure characterization is given below.
Aspirin conjugates 1–4 have shown ester peaks in FTIR spectra. The FTIR (KBr) spectrum of pullulan-aspirin conjugate 2 (Fig. 1) has shown ester absorptions at 1744, aromatic C–H absorption at 2926 and unreacted –OH absorption at 3437 cm−1. Nevertheless, pullulan-aspirin conjugates 1–4 have displayed aromatic C–H absorptions, hydroxyl group absorption and CH2 (polymer) absorption signals as well in the FTIR spectra that indicate the success of esterification reactions.
The 1H NMR (400 MHz) spectra of pullulan-aspirin conjugates were recorded in DMSO-d6. The typical spectrum of sample 1 (Fig. 2) showed the presence of the aromatic ring coupled with pullulan polymer backbone as aromatic protons were detectable at δ 6.94–7.86 ppm. The aromatic H-9 and H-11 overlapped and absorbed at δ 6.94 ppm while H-8 and H-10 absorbed at 7.86 and 7.50 ppm, respectively.
These results have demonstrated that the unsaturated system is not destroyed during the entire course of the reaction. Broad signals of aromatic protons also suggest the covalent attachment of aromatic system onto different positions of hydroxyl groups in the pullulan polymer chains. Protons of pullulan polymer backbone/anhydroglucose unit (AGU) were detectable at 3.35–5.70 (AGU-H-1-6) ppm. The 1H NMR spectrum has proved that samples fabricated by using the CDI method are highly pure as no sign of any impurity is detected in spectrum. The DS was also possible to be calculated by the comparison of signal intensities of the aromatic ring absorption with AGU-Hs. The DS of the samples 1–4 was found in the range of 0.32–0.40 (see Table 1).
A typical 13C NMR spectrum of sample 1 recorded in DMSO-d6 shows the characteristic signals at δ 170.49 and 168.99 for the carbonyl absorptions of acetyl moiety onto aspirin and ester (CO) linkage with the polymer, respectively indicating success of the reaction (Fig. 3). It is common to observe two or three signals of C-10 of three sugars of maltotriosyl unit of the pullulan because of geometrically diverse environment. Nevertheless, C-10 absorbed at 101.84 and 95.99 ppm for pullulan-aspirin conjugate 1. The C-11-14 of pullulan maltotriose unit appears in the range of 67.5–80.03 ppm. The 13C NMR spectrum of pullulan-aspirin conjugate 1 is found comparable for maltotriose region with the NMR spectra of pullulan nonaacetate (Tezuka, 1998), and pullulan abietates (Hussain and Heinze, 2008).
3.2 Thermal stability analysis of pullulan-aspirin conjugates
The initial decomposition (Tdi), maximum decomposition temperature (Tdm) and final decomposition (Tdf) of the pullulan-aspirin conjugate 3 were assessed by thermogravimetry (TG) and differential thermogravimetry (DTG) curves. The thermal decomposition data of pullulan-aspirin conjugate 3 are shown in Table 2 while the TG Curves and DTG thermograms of sample 3 are shown in Fig. 4.
| Sample | Step | Tdi, Tdm, Tdf | Method | R2 | n | M (Slope) | Ea (kJ/mol) | ln Z | Z (s−1) |
|---|---|---|---|---|---|---|---|---|---|
| Pullulan-aspirin conjugate | I | 135, 213, 289 | Friedman | 0.991 | – | −4189 | 34.83 | 6.905 | 9.9 × 102 |
| Broido | 0.999 | – | −5545 | 46.10 | 11.07 | 6.4 × 104 | |||
| Chang | 0.997 | 1 | −3998 | 33.24 | 6.605 | 7.4 × 102 | |||
| II | 316, 365, 411 | Friedman | 0.979 | – | 33,638 | 279.68 | −51.93 | 3.6 × 1022 | |
| Broido | 0.999 | – | −32,961 | 274.05 | 51.48 | 2.3 × 1022 | |||
| Chang | 0.999 | 1 | −30,604 | 254.46 | 49.44 | 3.0 × 1021 | |||
| III | 529, 623, 643 | Friedman | 0.995 | – | −23,415 | 194.68 | 25.34 | 1.0 × 1011 | |
| Broido | 0.999 | – | −27,357 | 227.45 | 31.00 | 2.9 × 1013 | |||
| Chang | 0.986 | 1 | −23,982 | 199.39 | 26.32 | 2.7 × 1011 | |||
| Pullulan | I | 278, 320, 371 | Friedman | 0.988 | – | 32,497 | 270.19 | 53.72 | 2.1 × 1023 |
| Broido | 0.999 | – | −19,683 | 163.65 | 33.13 | 2.4 × 1014 | |||
| Chang | 0.999 | 1 | −18,537 | 154.13 | 32.63 | 1.5 × 1014 | |||
| Aspirin | I | 134, 152, 189 | Friedman | 0.999 | – | 16,634 | 138.30 | 38.53 | 5.4 × 1016 |
| Broido | 0.991 | – | −19,598 | 162.95 | 45.46 | 5.5 × 1019 | |||
| Chang | 0.997 | 1 | −19,176 | 159.43 | 46.49 | 1.6 × 1020 | |||
| Friedman | 0.998 | – | −10,579 | 87.96 | 17.99 | 6.5 × 107 | |||
| II | 250, 327, 356 | Broido | 0.999 | – | −15,787 | 131.26 | 26.45 | 3.1 × 1011 | |
| Chang | 0.999 | 1 | −12,568 | 104.5 | 21.71 | 2.7 × 109 | |||

The thermograms of pullulan-aspirin conjugate 3 have shown three-step degradation. The conjugate 3 was found thermally stable up to 135 °C (Tdi) with 14.2% weight loss in overall first step degradation. However Tdm and Tdf were found at 213 and 289 °C, respectively which are considerably higher than pure aspirin (152, 189 °C) indicating the extra stability imparted in pullulan-aspirin conjugate 3. The pullulan-aspirin conjugate 3 has shown major degradation in step-II. An overall weight loss of 67.68% was observed in this step. A Tdm 365 °C was observed for the conjugate 3 which is higher than Tdm of step-II for pure aspirin (327 °C). This result has indicated that aspirin becomes 38 °C more stable in conjugates. In step III, a slow degradation proceeds to completion leaving behind 0.85% char yield at 643 °C. It is concluded from above mentioned results that pullulan-aspirin conjugates are thermally more stable than pure aspirin and pullulan.
From thermogravimetric analysis, some kinetic parameters like activation energy (Ea), order of reaction (n) and frequency factor (Z) were determined. . To study the kinetic parameters (Ea and Z) of thermal degradation, Friedmann and Broido models were employed. The order of reaction n was calculated by using the Chang model. The details on the kinetics and comparison of the results are summarized in Table 2. The results have indicated comparable Ea values of the step-I degradation of conjugate 3, i.e., 34.83, 46.10 and 33.24 kJ/mol as calculated by Friedmann, Broido and Chang models, respectively. Applying same models, aspirin has shown Ea values 138, 163 and 159 kJ/mol, for the relevant first step. The n was calculated through the Kissinger model which indicated the first order kinetic of the said degradation steps. The conjugate 3 has shown Ea values of 280, 274 and 254 kJ/mol, respectively for step-II degradation, while pure aspirin showed Ea values 88, 131 and 104 kJ/mol, respectively for step-II. As all the Ea values are not very high therefore it is roughly estimated that degradation generally follows first order kinetics. It is noted from Table 2 that the application of different kinetic models on the TG curves gives almost comparable results.
3.3 Transmission electron microscopy (TEM)
The TEM analyses were carried out to study the behavior of pullulan-aspirin conjugates in solution by the solvent diffusion method. The TEM images of the molecular self-assembly have revealed the formation of nanoparticles in case of sample 3 (Fig. 5) in the range of 500–680 nm for the major population of nanoparticles. Nanoparticle formation is indicative of the fact that there lies a very good balance of hydrophobicity and hydrophilicity in sample 3 that favored the formation of nanoparticles of the water soluble biopolymer pullulan. Such nanoparticulate drug design for aspirin MPDs onto pullulan may lead to improved pharmacokinetic profile of aspirin.
4 Conclusion
A water soluble and biocompatible polysaccharide, i.e., pullulan was successfully evaluated to be used as a valuable covalent drug carrier for NSAIDs, i.e., aspirin. The newly synthesized MPDs of aspirin appeared thermally highly stable and organo-soluble. All of the products were highly pure and thoroughly characterized. Pullulan-aspirin conjugates self-assemble in nanoparticles in useful size regimen, therefore, said novel MPDs of aspirin could be highly potent for its better pharmacokinetic profile and controlled release of aspirin.
Acknowledgement
K. Abbas gratefully acknowledges the financial support provided by the Higher Education Commission (HEC) of Pakistan under “HEC Indigenous 5000 fellowships Scheme”.
References
- Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers. Int. J. Pharm.. 2006;316:68-73.
- [Google Scholar]
- A simple, sensitive graphical method of treating thermogravimetric analysis data. J. Polym. Sci. Part A-2 Polym. Phys.. 1969;7:1761-1773.
- [Google Scholar]
- Biomedical applications of maleic anhydride copolymers. Die Makromol. Chem.. 1990;191:529-536.
- [Google Scholar]
- Decomposition behavior of polyurethanes via mathematical simulation. J. Appl. Polym. Sci.. 1994;53:1759-1769.
- [Google Scholar]
- Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J. Controlled Release. 2001;74:135-146.
- [Google Scholar]
- Kinetics of thermal degradation of char-forming plastics from thermogravimetry. Application to a phenolic plastic. J. Polym. Sci. Part C Polym. Symp.. 1964;6:183-195.
- [Google Scholar]
- Kinetics of thermal degradation of char-forming plastics from thermogravimetry. Application to a phenolic plastic. Carbohydr. Polym.. 2000;42:393-400.
- [Google Scholar]
- Acylation of cellulose with n, n‘-carbonyldiimidazole-activated acids in the novel solvent dimethyl sulfoxide/tetrabutylammonium fluoride. Macromol. Rapid Commun.. 2004;25:916-920.
- [Google Scholar]
- First report on a new esterification method for cellulose. Polym. News. 2004;29:14-17.
- [Google Scholar]
- Macromolecular prodrugs of aspirin with HPMC: a nano particulate drug design, characterization, pharmacokinetic studies. J. Polym. Sci. Part A Polym. Chem.. 2009;47:4202-4208.
- [Google Scholar]
- An efficient esterification of pullulan using activated carboxylic acid anhydrides with iodine. Collect. Czech. Chem. Commun.. 2010;75:133-143.
- [Google Scholar]
- An efficient acetylation of dextran using in situ activated acetic anhydride with iodine. J. Serb. Chem. Soc.. 2010;75:165-173.
- [Google Scholar]
- Macromolecular prodrugs of aspirin with HPMC: a nano particulate drug design, characterization, pharmacokinetic studies. Macromol. Res.. 2011;19:1296-1302.
- [Google Scholar]
- Fabrication of potential macromolecular prodrugs of aspirin and diclofenac with dextran. Pak. J. Pharm. Sci.. 2011;24:575-581.
- [Google Scholar]
- Hydroxypropylcellulose-aceclofenac conjugates: high covalent loading design, structure characterization, nano-assemblies and thermal kinetics. Cellulose. 2013;20:717-725.
- [Google Scholar]
- Prospectives of biodegradable polysaccharides for site specific drug delivery to the colon. J. Pharm. Pharm. Sci.. 2007;10:86-128.
- [Google Scholar]
- Evaluation of succinylated pullulan for long-term protein delivery in poly(lactide-co-glycolide) microspheres. Macromol. Res.. 2010;18:812-819.
- [Google Scholar]
- NSAID’s and selectively COX-2 inhibitors as potential chemoprotective agents against cancer. Arab. J. Chem.. 2013;6:1-23.
- [Google Scholar]
- Synthesis and characterization of cellulose α-lipoates: a novel material for adsorption onto gold. Polym. Bull.. 2006;57:857-863.
- [Google Scholar]
- Pure, transparent-melting starch esters: synthesis and characterization. Macromol. Rapid Commun.. 2011;32:1312-1318.
- [Google Scholar]
- Synthetic approaches for total chemical synthesis of proteins and proteins like macromolecules of branched architecture. Curr. Org. Chem.. 2006;10:1727-1744.
- [Google Scholar]
- Preparation of pullulan-g-poly(L-lysine) and it’s evaluation as a gene carrier. Macromol. Res.. 2012;20:667-672.
- [Google Scholar]
- Polymer colon drug delivery system and their application to peptides, proteins and nucleic acids. Am. J. Drug Deliv.. 2005;3:171-204.
- [Google Scholar]
- Macromolecular drugs: novel strategy in target specific drug delivery. J. Clin. Diagn. Res.. 2008;2:1020-1023.
- [Google Scholar]
- Biodegradable nanogel-integrated hydrogels for sustained protein delivery. Macromol. Res.. 2012;20:266-270.
- [Google Scholar]
- Development of drug delivery systems for macromolecular drugs. Yakugaku Zasshi. 1996;116:519-532.
- [Google Scholar]
- Assignment of chemical shifts of the acetyl proton and acetyl carbonyl carbons by 2D-NMR spectroscopy. Carbohydr. Res.. 1998;305:155-161.
- [Google Scholar]
- Recent advances in drugs and prodrugs design of chitosan. Curr. Pharm. Des.. 2008;14:1311-1326.
- [Google Scholar]
